Literature DB >> 17960060

Impaired vascular reactivity in patients with chronic kidney disease.

Fabian Tetzner1, Alexandra Scholze, Antje Wittstock, Walter Zidek, Martin Tepel.   

Abstract

BACKGROUND: Patients with chronic kidney disease (CKD) show increased cardiovascular morbidity. We hypothesized that vascular properties which can be routinely evaluated noninvasively are related to different stages of CKD and their clinical and biochemical characteristics.
METHODS: Arterial vascular properties were quantified by the reflective index using digital photoplethysmography in 260 patients with CKD. Patients were grouped according to estimated glomerular filtration rate (eGFR). Additional measurements were performed in 50 healthy control subjects.
RESULTS: In patients with CKD stage 1 and 2 (n = 115; age 65 +/- 1 years) the reflective index was 30 +/- 1%, whereas in patients with CKD stage 3 and 4 (n = 60; age 72 +/- 1 years) the reflective index was 36 +/- 1%, and in patients with CKD stage 5 (n = 85; age 64 +/- 1 years) the reflective index was 36 +/- 1% (p < 0.01 by Kruskal-Wallis test) indicating increased arterial stiffness in advanced CKD. Arterial vascular reactivity was significantly impaired in patients with advanced stages of CKD (stage 1 and 2, 78 +/- 12%; stage 3 and 4, 32 +/- 12%; stage 5, 33 +/- 12%; p < 0.01). Univariate analysis showed a significant correlation of the reflective index and eGFR (Pearson r = -0.24; p < 0.0001). Multivariate regression analysis showed an independent association of the reflective index and eGFR (adjusted correlation coefficient, -0.24; p < 0.001).
CONCLUSION: The advanced stages of CKD are associated with increased vascular stiffness and impaired vascular reactivity and these changes are already present in CKD stage 3 and 4. 2007 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2007        PMID: 17960060     DOI: 10.1159/000110091

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  5 in total

1.  Relationship between stage of kidney disease and incident heart failure in older adults.

Authors:  C Barrett Bowling; Margaret A Feller; Marjan Mujib; Pushkar P Pawar; Yan Zhang; O James Ekundayo; Inmaculada B Aban; Thomas E Love; Paul W Sanders; Stefan D Anker; Gregg C Fonarow; Ali Ahmed
Journal:  Am J Nephrol       Date:  2011-07-04       Impact factor: 3.754

2.  Reversible cerebral vasoconstriction syndrome and antivitamin K anticoagulation: challenges of an unusual association.

Authors:  Amina Nasri; Malek Mansour; Amel Kacem; Jamel Zaouali; Ridha Mrissa
Journal:  Neurol Sci       Date:  2017-05-13       Impact factor: 3.307

3.  Does chronic kidney disease modify the association between body mass index and cardiovascular disease risk factors.

Authors:  Nisha Bansal; Eric Vittinghoff; Laura Plantinga; Chi-Yuan Hsu
Journal:  J Nephrol       Date:  2012 May-Jun       Impact factor: 3.902

4.  Arterial stiffness and renal impairment in non-proteinuric type 2 diabetic patients.

Authors:  Keiko Nakao; Takashi Uzu; Shin-Ichi Araki; Shinji Kume; Naoko Deji; Masami Chin-Kanasaki; Hisazumi Araki; Keiji Isshiki; Toshiro Sugimoto; Hiromichi Kawai; Yoshihiko Nishio; Atsunori Kashiwagi; Hiroshi Maegawa
Journal:  J Diabetes Investig       Date:  2012-02-20       Impact factor: 4.232

Review 5.  Nrf2 Activation in Chronic Kidney Disease: Promises and Pitfalls.

Authors:  Ana Karina Aranda-Rivera; Alfredo Cruz-Gregorio; José Pedraza-Chaverri; Alexandra Scholze
Journal:  Antioxidants (Basel)       Date:  2022-06-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.